Iron Substitution After Upper Gastro-Intestinal Bleeding

• Status: Completed
• Trial end date: 2013-04-01
• Target enrollment: 0
• Participant gender: All

Summary

The trial is a double-blind randomized trial designed to examine whether compliant iron therapy (intravenous or oral) for 3 months after discharge increases hemoglobin levels more and faster than no treatment - in patients with acute bleeding from upper gastrointestinal tract. The trial will include 126 patients at Aarhus University Hospital. In addition to efficacy assessment quality of life assessment and health economic calculations between the treatments will be compared.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: University of Aarhus
• Collaborators: GCP-unit at Aarhus University Hospital, Aarhus, Denmark; Vifor Pharma
• Treatments: Iron

Criteria

Inclusion Criteria:

• Acute upper gastrointestinal bleeding

• Anemia

Exclusion Criteria:

• Liver disease

• Terminal cancer

• Kidney disease

• variceal bleeding

• Pregnancy